Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by Sonny7on Oct 25, 2019 1:40pm
118 Views
Post# 30270339

RE:RE:RE:RE:RE:CEO Said ...

RE:RE:RE:RE:RE:CEO Said ...I’m glad you showed that three year chart. It’s a classic. The company had its struggles in the beginning but things changed with the enhanced technology and the spikes in the share prices correlate to regulatory approvals as it trends down in share price, the highest price shown with the Health Canada approval. The chart shows that as the company becomes stronger the share price becomes weaker. The potential is recognized and the buzzards that have been circling overhead now swoop in to manipulate the stock after each piece of positive news for the purpose of accumulating and they are bloody good at it. This is why some people don’t understand price drops after news or stock market patterns that defy normal human logic because there is NOT a stock ANYWHERE that isn’t manipulated. 

So, whatever your motive here, run for your life CC. The sky is falling and those buzzards eat little chickens like you. 
Bullboard Posts